NMRK2 and cancer: Despite previous findings, unsolved questions remain: (1) how common muscle NAD+ depletion and Nrk2 downregulation are in CC induced by distinct tumors, (2) is NAD+ metabolism disturbed in other tissues beyond the skeletal muscle, and (3) can NAD+ repletion with NA mitigate the symptoms of cancer cachexia.